Gain Therapeutics Inc. (GANX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.76
0.02 (1.15%)
At close: Sep 05, 2025, 3:59 PM
1.78
1.14%
After-hours: Sep 05, 2025, 07:54 PM EDT

Gain Therapeutics Revenue

Gain Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Gain Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
23
Market Cap
63.27M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 -100.00%
Dec 31, 2023 55.18K -60.62%
Dec 31, 2022 140.11K -15.08%
Dec 31, 2021 164.99K +471.29%
Dec 31, 2020 28.88K -30.07%
Dec 31, 2019 41.3K +100.40%
Dec 31, 2018 20.61K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.